Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001354488-12-004307
Filing Date
2012-08-16
Accepted
2012-08-16 13:26:51
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 tdlp_s1a.htm S-1/A 2620502
2 CONSENT tdlp_ex231.htm EX-23.1 3499
3 img001.jpg GRAPHIC 35838
4 img002.jpg GRAPHIC 49408
  Complete submission text file 0001354488-12-004307.txt   7266044

Data Files

Seq Description Document Type Size
5 immy-20120630.xml EX-101.INS 955736
6 immy-20120630.xsd EX-101.SCH 34966
7 immy-20120630_cal.xml EX-101.CAL 42506
8 immy-20120630_def.xml EX-101.DEF 80098
9 immy-20120630_lab.xml EX-101.LAB 251328
10 immy-20120630_pre.xml EX-101.PRE 177985
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-182846 | Film No.: 121039479
SIC: 2834 Pharmaceutical Preparations